Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

280.18
-6.1100-2.13%
Post-market: 280.180.00000.00%19:30 EDT
Volume:158.24K
Turnover:44.66M
Market Cap:5.59B
PE:28.85
High:286.27
Open:286.27
Low:279.87
Close:286.29
52wk High:326.63
52wk Low:157.52
Shares:19.94M
Float Shares:19.35M
Volume Ratio:0.86
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:5.77
PE(LYR):45.71

Loading ...

Deals of the day-Mergers and acquisitions

Reuters
·
Apr 28

Ligand price target raised to $260 from $250 at BofA

TIPRANKS
·
Apr 28

Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Eton Pharmaceuticals (ETON) and Ligand Pharma (LGND)

TIPRANKS
·
Apr 27

XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday

Benzinga_recent_news
·
Apr 27

Ligand Pharma to acquire fellow biotech royalty rights buyer XOMA for $739 million

Reuters
·
Apr 27

Ligand to buy XOMA Royalty for $39 per share in cash, CVR included

Reuters
·
Apr 27

XOMA Royalty Corp - Stockholders to Receive One CVR per Share for 75% of Net Litigation Proceeds

THOMSON REUTERS
·
Apr 27

XOMA Royalty Corp - Ligand Increases 2026 Revenue Guidance to $270 Mln-$310 Mln; Royalties $225 Mln-$250 Mln

THOMSON REUTERS
·
Apr 27

XOMA Royalty Corp - Ligand Raises 2026 Adj EPS Guidance to $8.50-$9.50; Expects $1.50 Accretion to Adj EPS in 2027

THOMSON REUTERS
·
Apr 27

XOMA Royalty Corp - Ligand to Buy XOMA Royalty for $39.00 per Share in Cash, Equity Value $739 Mln

THOMSON REUTERS
·
Apr 27

XOMA Shares Gain 5.4% Premarket After Report Ligand Pharmaceuticals Buying Co for Nearly $740 Mln

THOMSON REUTERS
·
Apr 27

BRIEF-Ligand Pharmaceuticals Is Buying Xoma For Nearly $740 Million - WSJ

Reuters
·
Apr 27

Xoma Royalty Shares Edge Up Premarket on Report of Takeover by Ligand

Dow Jones
·
Apr 27

Ligand Pharmaceuticals Is Buying XOMA for Nearly $740 Million - WSJ

THOMSON REUTERS
·
Apr 27

Ligand Pharmaceuticals' Deal for XOMA Would Value XOMA at $39 a Share - WSJ

THOMSON REUTERS
·
Apr 27

Ligand Pharmaceuticals announces annual shareholder meeting

Reuters
·
Apr 22

Ligand Pharmaceuticals Is Maintained at Buy by Citigroup

Dow Jones
·
Apr 16

Ligand Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 14

Ligand Pharma (LGND) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Apr 14

Ligand Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $243 From $239

THOMSON REUTERS
·
Apr 14